Recruiting
Phase 2

TNF Blockade

Sponsor:

Endeavor Health

Code:

NCT06062875

Conditions

Benign Prostatic Hyperplasia (BPH)

Eligibility Criteria

Sex: Male

Age: 45 - 70+

Healthy Volunteers: Not accepted

Interventions

Adalimumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-27. This information was provided to ClinicalTrials.gov by Endeavor Health on 2024-11-21.